Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PepGen, Inc
PepGen Announces Positive Preclinical Data for PGN-EDO53, PGN-EDO45 and PGN-EDO44, Three Novel Duchenne Muscular Dystrophy Candidates
November 14, 2022
From
PepGen, Inc
Via
GlobeNewswire
Tickers
PEPG
PepGen Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
November 10, 2022
From
PepGen, Inc
Via
GlobeNewswire
Tickers
PEPG
PepGen to Participate in the Stifel 2022 Healthcare Conference
November 08, 2022
From
PepGen, Inc
Via
GlobeNewswire
Tickers
PEPG
PepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress
October 13, 2022
From
PepGen, Inc
Via
GlobeNewswire
Tickers
PEPG
PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
September 28, 2022
From
PepGen, Inc
Via
GlobeNewswire
Tickers
PEPG
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.